REDACTEDImmunic, Inc. • October 20th, 2020 • Pharmaceutical preparations
Certain identified information, indicated by [***], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.
Form of Guarantee Agreement between the European Investment Bank and Immunic, Inc. and Immunic AG Luxembourg and Munich [●] 2020Guarantee Agreement • October 20th, 2020 • Immunic, Inc. • Pharmaceutical preparations
The European Investment Bank having its seat at 100 blvd Konrad Adenauer, Luxembourg, L-2950 Luxembourg, represented by [●] and [●] (the "Bank")
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 TherapyImmunic, Inc. • October 20th, 2020 • Pharmaceutical preparations
· European Investment Bank and Immunic sign a financing agreement of up to €24.5 million to support the development of Immunic’s lead asset, IMU-838, in moderate COVID-19
